invivodata and PRO Consulting Announce Industry, Educational Events.(Conference news)

Pittsburgh, PA (Vocus/PRWEB) January 31, 2011

invivodata inc.(R), the industry leader in patient reported outcomes (PRO) solutions and services for global clinical research, along with its scientific and regulatory consulting division, PRO Consulting(R), today announced a series of upcoming industry conferences and company-sponsored events which will feature presentations by members of invivodata and PRO Consulting's scientific and regulatory teams.

Scientific and regulatory experts from invivodata and PRO Consulting will share their knowledge on the collection of PRO data at the following events:

*     American Academy of Dermatology (AAD) Annual Meeting -- February 4-8, 2011; New Orleans, LA. Dr. Jean Paty will present a poster entitled "Developing a Symptom-based Patient Reported Outcome Instrument for use in Regulated Psoriasis Clinical Trials."

*     Webinar: "Leveraging the Value of ePRO Data Early in Clinical Trials" -- March 1, 2011. Dr. Saul Shiffman will review the scientific and regulatory rationale for developing and validating PRO measures and implementing electronic PRO measures in Phase II clinical trials. The presentation will review the real-world value of using ePRO early in clinical development, including the practical benefits of justifying study investment to both internal and external audiences.

*     Drug Information Association (DIA) Annual EuroMeeting -- March 28-30, 2011; Geneva, Switzerland. Dr. Brian Tiplady will present "Web-based Assessments: The Internet is an Emerging Modality in Patient Reported Outcomes."

*     PROficiency[TM] 2011, invivodata's Annual PRO Conference -- April 12-14, 2011; Fort Lauderdale, FL. invivodata and PRO Consulting scientists will join international clinical researchers and regulatory experts in presenting current information on the successful use of PRO and ePRO throughout all stages of clinical development.

*     American Pain Society (APS) -- May 19-21, 2011; Austin, TX. Peter Black will present "Use of Pain Instruments as Endpoints in Regulatory Submissions: Implications of the US FDA's new Patient Reported Outcomes (PRO) Guidance, and "Assessing the Equivalence of Electronic and Paper Data Collection of Brief Pain Inventory (BPI) data in Rheumatoid Arthritis."

For additional information on these events and other opportunities to meet with the invivodata and PRO Consulting teams, please visit http://www.invivodata.com/news-events/events/.

About invivodata

invivodata is the only fully-integrated PRO Solutions Organization delivering regulatory-proven strategic consulting and practical ePRO solutions to biopharmaceutical companies who depend upon patient-centered research. From crafting PRO measurement strategy to collecting PRO data electronically, invivodata helps its customers strategically use patient reported data to support labeling claims, enhance market access, and meet other clinical program objectives. Through partnerships with leading CROs and eClinical technology providers, invivodata seamlessly integrates into the clinical trial ecosystem, helping to minimize operational risk and maximize efficiencies. invivodata's solutions have been used in over 300 clinical programs and are built upon the industry-leading ePRO system in delivering primary efficacy data for global drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, PA., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, CA., USA. For more information, visit http://www.invivodata.com.

About PRO Consulting

PRO Consulting, a division of invivodata, inc., provides consulting services to help clinical research teams effectively develop, execute, and document patient reported outcome (PRO) strategies to support their clinical research objectives. The PRO Consulting team has worked on over 150 clinical studies in 50+ indications, has more than 265 years of cumulative experience in psychometrics, PRO study design, and migrating and validating electronic solutions to collect PRO data, and has extensive experience working with the FDA and other regulatory bodies. For more information please visit http://www.patientreported.com.

# # #

Read the full story at http://www.prweb.com/releases/2011/1/prweb8101292.htm